Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02264249 · ClinicalTrials.gov registry record
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
A clinical trial of Colonoscopy and Esophagogastroduodenoscopy, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 449
- Enrollment target
- 1
- Study location
NCT02264249 is a study of Colonoscopy and Esophagogastroduodenoscopy that has completed, run by The Cleveland Clinic. The registered enrollment target is 449 participants, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT02264249, a study of Colonoscopy and Esophagogastroduodenoscopy, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 449 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.
Conditions Studied
Interventions
- OTHER Esophagogastroduodenoscopy and colonoscopy split dose prep
- OTHER Esophagogastroduodenoscopy and colonoscopy Evening before colonoscopy prep
- OTHER Esophagogastroduodenoscopy and colonoscopy Same day prep colonoscopy preparation
Study Locations (1)
Florida
- Cleveland Clinic Florida - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 449 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02264249
The ClinicalTrials.gov registry entry for NCT02264249 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 449 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 479-participant average among 20 other Colonoscopy trials with a reported enrollment target. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colonoscopy appearing as the primary indexed condition, and to 3 interventions - of which Esophagogastroduodenoscopy and colonoscopy split dose prep is the first listed.
NCT02264249 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02264249 about?
NCT02264249 is a clinical study titled "Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation". The purpose of this study is to determine residual gastric volume and residual gastric pH in patients undergoing combined EGD and colonoscopy comparing the standard single dose prep with the split dose bowel preparation and same day bowel preparations.
What is the current status of trial NCT02264249?
This trial is currently completed. The enrollment target is 449 participants. The study started on 2014-09. Estimated completion is 2016-02.
What conditions does trial NCT02264249 study?
This clinical trial studies the following conditions: Colonoscopy, Esophagogastroduodenoscopy.
What interventions are being tested in trial NCT02264249?
The interventions under investigation include: Esophagogastroduodenoscopy and colonoscopy split dose prep (OTHER), Esophagogastroduodenoscopy and colonoscopy Evening before colonoscopy prep (OTHER), Esophagogastroduodenoscopy and colonoscopy Same day prep colonoscopy preparation (OTHER).
Who is sponsoring clinical trial NCT02264249?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02264249 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
RECRUITING
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.